A phase 1/2a clinical trial to assess safety and immunogenicity of an adenoviral-vectored capsular group B meningococcal vaccine
1. 系统已在2025-07-01 09:11:46对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI: 10.1126/scitranslmed.adn1441
文献链接: https://www.science.org/doi/10.1126/scitranslmed.adn1441
其他信息:
出版社: American Association for the Advancement of Science (AAAS)
作者: Christina Dold; Blanché Oguti; Laura Silva-Reyes; Anna Stanzelova; Meriel Raymond; Catherine C. Smith; Maria Moore; Anna Barton; Edward M. Choi; Emma Plested; Kiarash Tanha; Jennifer Louth; Ann Holland; Robert Cook; Jessica King; Jay Lucidarme; Ray Borrow; Adrian V. S. Hill; Peter T. Beernink; Xinxue Liu; Andrew J. Pollard; Christine S. Rollier
